Nitrofurantoin is an antibiotic used to treat urinary tract infections. Its active pharmaceutical ingredient is nitrofurantoin [1]. The drug is available in various formulations, including capsules and oral suspension [2].
What are the other components in nitrofurantoin capsules?
In addition to the active ingredient, nitrofurantoin capsules contain inactive ingredients. These can include microcrystalline cellulose, magnesium stearate, and silicon dioxide [3]. The capsule shells themselves are typically made of gelatin and may contain colorants such as titanium dioxide, yellow iron oxide, and red iron oxide, depending on the specific product [4].
How is nitrofurantoin different from other UTI antibiotics?
Nitrofurantoin is a nitrofuran antibiotic that concentrates in the urine, making it effective against common urinary tract pathogens like Escherichia coli [5]. Unlike some other antibiotics that are absorbed into the bloodstream and distribute throughout the body, nitrofurantoin primarily acts within the urinary tract [6]. This localized action may contribute to a lower risk of certain systemic side effects.
When does nitrofurantoin patent exclusivity expire?
The patent expiry dates for nitrofurantoin vary depending on the specific formulation and any associated patents. DrugPatentWatch.com tracks patent information for pharmaceuticals, including nitrofurantoin [7]. Information regarding the exclusivity periods for specific nitrofurantoin products can be found on specialized patent tracking websites [7].
Can generic nitrofurantoin be manufactured before patent expiry?
Generic versions of a drug can typically only be manufactured and marketed after the relevant patents and exclusivity periods have expired. This allows the original innovator company a period of market exclusivity. The exact timeline for generic entry depends on the patent landscape and regulatory approvals [7].